CAU
AGL icon

Caxton Associates (UK)’s Agilon Health AGL Stock Holding History

Caxton Associates (UK)’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$547K Buy
+5,100
New +$334K 0.01% 520
2025
Q3 		– Sell
-15,315
Closed -$881K – 683
2025
Q2 		$881K Buy
15,315
+1,194
+8% +$95.8K 0.02% 338
2025
Q1 		$1.53M Buy
+14,121
New +$1.23M 0.05% 224

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NPCM
North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Caxton Associates (UK)'s AGL Position: Q2 2026 in Review

Caxton Associates (UK) opened a new position in Agilon Health (AGL) in Q2 2026: 5,100 shares worth $547K. The stake represents 0.01% of the portfolio and ranks #520 among its holdings. This is a return to the name: Caxton Associates (UK) previously reported a position in AGL as recently as Q2 2025.

Caxton Associates (UK) first reported a position in AGL in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.53M in Q1 2025. 179 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Caxton Associates (UK) held 5,100 shares of Agilon Health worth $547K as of Q2 2026.
  • Agilon Health was a new Caxton Associates (UK) position in Q2 2026.
  • Agilon Health made up 0.01% of Caxton Associates (UK)'s portfolio in Q2 2026, its #520 holding.
  • Caxton Associates (UK) first reported a position in Agilon Health in Q1 2025 and has held it in 3 quarters since.
  • Caxton Associates (UK)'s Agilon Health position peaked at $1.53M in Q1 2025.
  • 179 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.